Most providers that mention insurance are offering to file paperwork from outside your network. PlushCare is actually in it, which is a materially different proposition.
It states in-network status with major carriers including Aetna, Humana and Cigna, with most in-network patients paying $30 or less per visit, on a $19.99 monthly membership. Without insurance an initial visit is $129.
Then the sentence that makes this page worth trusting: PlushCare states that GLP-1 medication out of pocket usually costs about $1,000 a month. It is not pretending the cash route is viable, which is more than several competitors manage.
The clinical model is stronger than the category norm
A live video visit with a physician is required — not a questionnaire reviewed asynchronously, which is how most of this market prescribes injectable medication. For a drug class with real contraindications, that is a meaningful difference in screening quality.
It also publishes an explicit position on not treating patients with symptoms of an active eating disorder. Almost nobody else in this category addresses that at all, and it is among the most important exclusions in weight-loss prescribing.
Price it against the manufacturer before assuming insurance wins
If your authorisation fails, LillyDirect sells Zepbound directly at $299 to $449 a month depending on dose — far below the $1,000 PlushCare cites for out-of-pocket GLP-1s generally. So the cash-pay fallback is not PlushCare's medication price; it is buying the drug elsewhere.
What PlushCare gives you either way is the prescription and the clinical relationship, at $19.99 a month plus a copay. That is cheap for real physician care, and it pairs sensibly with a manufacturer channel if coverage does not come through.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What Zepbound is, and what it costs at source
Zepbound is tirzepatide, approved by FDA for chronic weight management, and it produced the largest average reductions of any drug in this class — roughly 20 to 21% of body weight over 72 weeks at the highest doses. It is also approved for obstructive sleep apnoea in adults with obesity, which occasionally unlocks coverage where a weight-only prescription would be refused.
Eli Lilly sells it directly. LillyDirect publishes single-dose vials at $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg through 15 mg, with KwikPens across the same range. That is the reference price, and it is close enough to mid-market compounded tirzepatide that the comparison is worth running properly.
Before you buy branded from a reseller
- Check the manufacturer's own price first — NovoCare for Wegovy, LillyDirect for Zepbound. Resale prices range across an order of magnitude.
- Establish whether a membership or programme fee is charged on top of the medication.
- Ask what the price is at your expected maintenance dose, since branded pricing usually rises with dose.
- If you have type 2 diabetes, ask about Ozempic or Mounjaro through insurance before paying cash for anything.
- Confirm whether the provider will submit a prior authorisation, and what happens if it is denied.